Akane Sada

PHLDA1, another PHLDA family protein that inhibits Akt

H. Aburatani, K. Semba, R. Ohki, 2018, Cancer science.

Metabolic intervention that reduces glucose-insulin signaling suppresses the onset and progression of neuroendocrine tumors

R. Ohki, S. Hijioka, A. Yokoyama, 2022, bioRxiv.

Overall Shape Constraint of Alternating α/β-Hybrid Peptides Containing Bicyclic β-Proline.

R. Ohki, T. Ohwada, K. Yamaguchi, 2019, Organic letters.

PHLDA3 is an important downstream mediator of p53 in squamous cell carcinogenesis.

A. Kaneda, R. Ohki, K. Okumura, 2021, The Journal of investigative dermatology.

Elaboration of non-naturally occurring helical tripeptides as p53-MDM2/MDMX interaction inhibitors.

K. Tsumoto, R. Ohki, S. Nagatoishi, 2021, Chemical & pharmaceutical bulletin.

Non-naturally Occurring Helical Molecules Can Interfere with p53-MDM2 and p53-MDMX Protein-Protein Interactions.

R. Ohki, T. Ohwada, Misa Sayama, 2019, Chemical & pharmaceutical bulletin.

Metabolic intervention by low carbohydrate diet suppresses the onset and progression of neuroendocrine tumors

R. Ohki, S. Hijioka, N. Sakata, 2023, bioRxiv.